Similarly, studies in a number of cancers have found miR-101 to function as a tumor suppressor by targeting EZH2 [24, 25], yet it was also implicated as a promoter of growth in estrogen receptor (ER)-positive breast tumors by inducing the activation of Akt [25]. Here, AKT1 is linked to breast neoplasm.